Products

AngioWaveNet
Angiowave Imaging
Cardiology AI
AngioWaveNet is FDA-cleared AI software that enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories, integrating with existing Cath lab workflows.

See all 1 product →

About Angiowave Imaging

AngioWave Imaging is a healthcare AI company that develops AngioWaveNet, a post-processing medical AI technology designed to enhance the visualization of vascular structures during angiographic procedures. The company’s platform integrates with existing fluoroscopic angiography systems and utilizes deep-learning-based spatiotemporal enhancement processing (STEP™) to interpret motion, structure, and time-based image data.

This cardiac imaging AI software, which has FDA 510(k) clearance, aims to provide improved clarity imaging, thereby aiding cardiologists in diagnosing coronary artery disease more effectively, facilitating better clinical decision-making, and ultimately improving patient outcomes. AngioWaveNet is indicated for use by qualified physicians to assist in the analysis and interpretation of X-ray coronary angiographic cines, specifically to enhance the visibility of blood vessels, vascular structures, and related anatomical features.

The software is designed for seamless integration into existing Cath lab workflows, automatically processing angiographic cines after acquisition. This allows clinicians to review both original and enhanced versions side-by-side without delaying procedures. Furthermore, AngioWaveNet is compatible with standard DICOM formatted output from any imaging system vendor, making it a versatile tool for cardiac catheterization laboratories.

Focus Areas

AI in medical imaging fluoroscopic angiography enhancement vascular visualization coronary artery disease cardiac catheterization deep learning spatiotemporal enhancement processing

Business Intelligence

Key InvestorsDRADS Capital
TechnologyDeep-learning-based Spatiotemporal Enhancement Processing (STEP™), AngioWaveNet™, angiographic, spatio-temporal, convolutional, deep neural network. DICOM endpoint, cloud-based or on-premise/servers.
FDA Clearances1 cleared products (estimated)

What Physicians Need to Know

AI in Medical Imaging
AngioWave offers cardiac imaging AI software designed to enhance fluoroscopic angiograms through advanced post-processing.
Fluoroscopic Angiography Enhancement
Specializes in enhancing fluoroscopic angiograms, providing improved vessel visualization.
Vascular Visualization
The core technology, AngioWaveNetu2122, eases visualization of the vasculature in angiographic cines.
Coronary Artery Disease (CAD)
Aids cardiologists in diagnosing coronary artery disease more effectively by facilitating visualization of the vasculature.
Cardiac Catheterization Integration
Integrates directly into existing Cath lab workflows, processing angiographic cines automatically after acquisition.
Deep Learning & Spatiotemporal Enhancement Processing (STEPu2122)
Utilizes deep-learning-based Spatiotemporal Enhancement Processing (STEPu2122) to interpret motion, structure, and time-based image data, revealing vessel details not visible on unprocessed angiograms.
FDA 510(k) Clearance
AngioWave's cardiac imaging AI software has received FDA 510(k) clearance.
Retrospective Analysis Capability
The software can be applied to previously acquired angiograms, allowing for re-analysis with improved clarity.
Future Functionality: Reduced Radiation & Contrast
Investigational future products aim to enable reduced radiation and contrast use during procedures.
Physician Tip

AngioWave Imaging's technology, AngioWaveNetu2122, stands out for physicians by offering significantly improved visualization of vascular structures, which can lead to enhanced confidence and precision during complex interventions, especially in challenging cases like large patients (BMI > 40) and those with Chronic Total Occlusions (CTO). Unlike conventional filters, its deep-learning-based Spatiotemporal Enhancement Processing (STEPu2122) reveals details often missed in unprocessed angiograms. The seamless, automatic integration into existing cath lab workflows means minimal disruption and no procedural delays, allowing for immediate side-by-side review of original and enhanced images. Furthermore, the system is vendor-agnostic, compatible with standard DICOM output from any major imaging system, ensuring broad applicability without requiring new hardware. With minimal training required, physicians can quickly leverage this AI-powered tool to aid in faster procedural decision-making and potentially improve patient outcomes.

AngioWaveNetu2122 is designed for seamless integration into existing cardiac catheterization laboratory workflows. It is compatible with standard DICOM formatted output (DICOM XA format) from any fluoroscopic angiography system, including those from Philips, Siemens, GE, and Canon. The system can be deployed either cloud-based or on-premise, functioning as a DICOM endpoint for the imaging system. Enhanced images can be sent to a RIS/PACS for display in the cath lab. AngioWave has also implemented extensive cybersecurity and system security testing, operating within secure hospital networks and adhering to HIPAA-compliant standards for image handling, ensuring no patient-identifying data is transmitted outside the facility.

Products by Angiowave Imaging

1 product in the directory

AngioWaveNet
Angiowave Imaging
Cardiology AI
AngioWaveNet is FDA-cleared AI software that enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories, integrating with existing Cath lab workflows.

Reviews & Opinions

No web reviews on file yet for Angiowave Imaging. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Angiowave Imaging.

Loading videos...

Videos load interactively. If none appear, search YouTube for Angiowave Imaging →

View all on YouTube

Press & Coverage

FDA
AngioWaveNet 510(k) Premarket Notification
AngioWave Imaging Inc. received 510(k) clearance from the FDA for its AngioWaveNet device, an AI and machine learning system designed to enhance the visibility of blood vessels in X-ray coronary angiographic images. The device is intended for use during diagnostic coronary angiography procedures as a complement to standard angiographic cines.
2025-09
American Journal of Cardiology (Am J Cardiol)
AngioWave Artificial Intelligence-Assisted Analysis of Septal Collaterals for Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention
This peer-reviewed article discusses how AngioWave's AI-enhanced angiograms improve the interpretation of chronic total occlusion (CTO) angiograms for retrograde percutaneous coronary intervention (PCI), making them easier to interpret and showing similar predictive performance for collateral crossing despite lower collateral complexity.
2026-02
PitchBook
AngioWave Imaging 2026 Company Profile: Valuation, Funding & Investors
AngioWave Imaging is in the process of an Early Stage VC (Series B) funding round, aiming to raise $10 million, with a previous Seed Round raising $825K. The company develops post-processing medical AI technology to enhance visualization of vascular structures during angiographic procedures.
2026-02
JACC: Case Reports
First Clinical Use of a Novel AI-Based Imaging Tool to Enhance CTO PCI Planning
This article reports the first clinical use of AngioWave Imaging's AI-based spatiotemporal enhancement processing (STEP) software in percutaneous coronary intervention (PCI), which helped identify an antegrade crossing pathway and an epicardial collateral not visible on unprocessed angiograms, guiding a successful procedural strategy.
2025-12
ClinicalTrials.gov
CERROS Pilot Study
AngioWave Imaging is a sponsor of the CERROS Pilot Study, which aims to determine if a reduced radiation protocol with spatiotemporal enhancement software can produce similar quality angiographic images as standard techniques for patients undergoing diagnostic coronary angiography.
unknown
AngioWave Imaging
Future Functionality - AngioWave | AI Transforming Angiography
AngioWave Imaging highlights future functionalities of its AngioWaveNetu2122 system, including reduced radiation and contrast use, and applications in coronary artery calcification, vascular/trauma, neuro/nephrology, and pulmonary imaging, with some features currently for investigational use only and not yet FDA reviewed.
unknown
AngioWave Imaging
AngioWave | AI Transforming Angiography
AngioWaveNetu2122 is a post-processing AI compatible with any fluoroscopic angiography system in a cardiac catheterization laboratory, designed to enhance visualization of vasculature for patients with coronary artery disease.
unknown
AngioWave Imaging
FAQ's - AngioWave | AI Transforming Angiography
AngioWave is cardiac imaging AI software with FDA 510(k) clearance that enhances fluoroscopic angiograms through advanced post-processing, providing improved vessel visualization and integrating directly into existing Cath lab workflows.
unknown

Frequently Asked Questions

AngioWave Imaging's core product is AngioWaveNetu2122, an FDA 510(k) cleared cardiac imaging AI software. It utilizes deep-learning-based Spatiotemporal Enhancement Processing (STEPu2122) to analyze motion, structure, and time-based image data, revealing vessel details in fluoroscopic angiograms that may not be visible in unprocessed images. This significantly improves vascular visualization for conditions like coronary artery disease during cardiac catheterization procedures.
AngioWaveNet integrates seamlessly into existing Cath lab workflows by automatically processing angiographic cines post-acquisition, providing enhanced images almost immediately. It is compatible with standard DICOM formatted output from any major imaging system vendor (e.g., Philips, Siemens, GE, Canon). The software is FDA 510(k) cleared and adheres to HIPAA-compliant standards for image handling, operating within secure hospital networks without transmitting patient-identifying data externally.
AngioWave Imaging offers flexible pricing models, including annual software licensing or subscription-based access, which are typically tailored to Cath lab volume and specific hospital needs. Custom packages are available for early adopters and trial sites. The software is designed to be intuitive, requiring minimal training for clinicians and staff to begin using it effectively.
Clinicians using AngioWaveNet have reported improved visualization of vessel structures, leading to faster procedural decision-making and increased confidence in navigating complex anatomy. It has proven particularly useful for challenging cases such as large patients (BMI > 40) and those with Chronic Total Occlusions (CTOs), where it can reveal microchannels and collaterals not apparent on standard angiograms.
AngioWave Imaging is a privately held, venture capital-backed company, having recently secured a Series B funding round of $10M in February 2026. While specific formal partnerships with other companies are not detailed, they have a strong leadership team with extensive experience in AI and medical imaging, supported by a medical advisory board of prominent clinicians.
AngioWave Imaging is actively exploring future functionalities for AngioWaveNet, including features aimed at reduced radiation exposure, reduced contrast agent usage, and enhanced detection of coronary artery calcification. These advanced features are currently for investigational use only and have not yet received FDA review.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.